Sensei Biotherapeutics Inc. (SNSE) NASDAQ

$1.50 0.03 (1.70%)

Market Cap: $45.16M

As of 02/06/23 04:00 PM EST. Market closed.

(SNSE)

Sensei Biotherapeutics Inc. (SNSE) NASDAQ

$1.50 0.03 (1.70%)

Market Cap: $45.16M

As of 02/06/23 04:00 PM EST. Market closed.

Sensei Biotherapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company has developed a proprietary bacteriophage-based platform, ImmunoPhage™, that enables the rapid generation of immune activating therapeutic agents that fully engage the immune ... read more

Sensei Biotherapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company has developed a proprietary bacteriophage-based platform, ImmunoPhage™, that enables the rapid generation of immune activating therapeutic agents that fully engage the immune system. Using the ImmunoPhage™ platform, Sensei is developing a library of ImmunoPhage, called Phortress™, to target multiple tumor-associated antigens to create a personalized yet off-the-shelf cocktail approach for treating cancer patients. The platform enables efficient, scalable and cost-effective manufacturing to support all of Sensei’s clinical programs. The company’s most advanced immunotherapy, SNS-301, a first-in-class ImmunoPhage™ targeting the tumor antigen Aspartyl beta Hydroxylase (ASPH), is currently in a Phase 1/2 clinical trial in patients with advanced Squamous Cell Carcinoma of the Head and Neck. Earlier stage programs include SNS-401, a ImmunoPhage™ cocktail for the treatment of Merkel Cell Carcinoma, and SNS-VISTA, an antibody-based therapeutic targeting an immune checkpoint gene that inhibits anti-tumor immune responses called V-domain Ig suppressor of T cell activation (VISTA). read less

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Full Time Employees
56
Address
.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$1.45
Previous Close
$1.47
Days Range
$1.44 - $1.53
52 week range
$1.30 - $4.86
Volume
79,497
Avg. Volume (30 days)
27,340
Market Cap
$45.16M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
30,720,291
Open
$1.45
Previous Close
$1.47
Days Range
$1.44 - $1.53
52 week range
$1.30 - $4.86
Volume
79,497
Avg. Volume (30 days)
27,340
Market Cap
$45.16M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
30,720,291

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR SENSEI BIOTHERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Peyer JamesDirectorMar 02, 2022 Buy$3.201,2033,8505,231,488Jun 10, 2022, 02:18 PM
Cambrian BioPharma Inc10% OwnerMar 02, 2022 Buy$3.201,2033,8505,231,488Jun 10, 2022, 02:17 PM
Peyer JamesDirectorMar 23, 2021 Buy$14.349,500136,2304,798,293Apr 21, 2022, 04:25 PM
Peyer JamesDirectorFeb 18, 2021 Buy$19.7575214,8524,690,905Apr 21, 2022, 04:22 PM
Cambrian BioPharma Inc10% OwnerMar 23, 2021 Buy$14.349,500136,2304,798,293Apr 21, 2022, 04:19 PM
Cambrian BioPharma Inc10% OwnerFeb 18, 2021 Buy$19.7575214,8524,690,905Apr 21, 2022, 04:17 PM
Cambrian BioPharma Inc10% OwnerMar 02, 2022 Buy$3.201,2033,8505,231,989Mar 02, 2022, 01:42 PM
Peyer JamesDirectorMar 02, 2022 Buy$3.201,2033,8505,231,989Mar 02, 2022, 01:40 PM
Peyer JamesDirectorMar 01, 2022 Buy$3.602,4588,8495,230,786Mar 01, 2022, 06:55 PM
Peyer JamesDirectorFeb 28, 2022 Buy$3.60421515,228,328Mar 01, 2022, 06:55 PM
Cambrian BioPharma Inc10% OwnerFeb 28, 2022 Buy$3.60421515,228,328Mar 01, 2022, 06:53 PM
Cambrian BioPharma Inc10% OwnerMar 01, 2022 Buy$3.602,4588,8495,230,786Mar 01, 2022, 06:53 PM
Peyer JamesDirectorFeb 25, 2022 Buy$3.652,5009,1255,228,286Feb 28, 2022, 04:53 PM
Cambrian BioPharma Inc10% OwnerFeb 25, 2022 Buy$3.652,5009,1255,228,286Feb 28, 2022, 04:50 PM
Cambrian BioPharma Inc10% OwnerFeb 24, 2022 Buy$3.6315,00054,4505,225,786Feb 24, 2022, 07:15 PM
Cambrian BioPharma Inc10% OwnerFeb 23, 2022 Buy$3.802,5009,5005,210,786Feb 24, 2022, 07:15 PM
Peyer JamesDirectorFeb 24, 2022 Buy$3.6315,00054,4505,225,786Feb 24, 2022, 07:12 PM
Peyer JamesDirectorFeb 23, 2022 Buy$3.802,5009,5005,210,786Feb 24, 2022, 07:12 PM
Peyer JamesDirectorFeb 18, 2022 Buy$3.9715,00059,5505,208,286Feb 22, 2022, 11:36 AM
Peyer JamesDirectorFeb 17, 2022 Buy$4.174,94920,6375,193,286Feb 22, 2022, 11:36 AM
Cambrian BioPharma Inc10% OwnerFeb 18, 2022 Buy$3.9715,00059,5505,208,286Feb 22, 2022, 11:35 AM
Cambrian BioPharma Inc10% OwnerFeb 17, 2022 Buy$4.174,94920,6375,193,286Feb 22, 2022, 11:35 AM
Cambrian BioPharma Inc10% OwnerFeb 16, 2022 Buy$4.252,55110,8425,188,337Feb 16, 2022, 06:59 PM
Cambrian BioPharma Inc10% OwnerFeb 14, 2022 Buy$4.1810,00041,8005,185,786Feb 16, 2022, 06:59 PM
Peyer JamesDirectorFeb 16, 2022 Buy$4.252,55110,8425,188,337Feb 16, 2022, 06:54 PM
Peyer JamesDirectorFeb 14, 2022 Buy$4.1810,00041,8005,185,786Feb 16, 2022, 06:54 PM
Peyer JamesDirectorFeb 10, 2022 Buy$4.585,00022,9005,163,286Feb 14, 2022, 07:19 PM
Peyer JamesDirectorFeb 11, 2022 Buy$4.4012,50055,0005,175,786Feb 14, 2022, 07:19 PM
Cambrian BioPharma Inc10% OwnerFeb 11, 2022 Buy$4.4012,50055,0005,175,786Feb 14, 2022, 07:18 PM
Cambrian BioPharma Inc10% OwnerFeb 10, 2022 Buy$4.585,00022,9005,163,286Feb 14, 2022, 07:18 PM
Cambrian BioPharma Inc10% OwnerFeb 08, 2022 Buy$4.3310,00043,3005,158,286Feb 08, 2022, 06:42 PM
Cambrian BioPharma Inc10% OwnerFeb 04, 2022 Buy$4.452,50011,1255,148,286Feb 08, 2022, 06:42 PM
Cambrian BioPharma Inc10% OwnerFeb 03, 2022 Buy$4.6517,50081,3755,145,786Feb 08, 2022, 06:42 PM
Peyer JamesDirectorFeb 03, 2022 Buy$4.6517,50081,3755,145,786Feb 08, 2022, 06:40 PM
Peyer JamesDirectorFeb 08, 2022 Buy$4.3310,00043,3005,158,286Feb 08, 2022, 06:40 PM
Peyer JamesDirectorFeb 04, 2022 Buy$4.452,50011,1255,148,286Feb 08, 2022, 06:40 PM
Cambrian BioPharma Inc10% OwnerJan 28, 2022 Buy$4.228,90037,5585,128,286Jan 31, 2022, 11:30 AM
Cambrian BioPharma Inc10% OwnerJan 27, 2022 Buy$4.316,10026,2915,119,386Jan 31, 2022, 11:30 AM
Peyer JamesDirectorJan 28, 2022 Buy$4.228,90037,5585,128,286Jan 31, 2022, 11:26 AM
Peyer JamesDirectorJan 27, 2022 Buy$4.316,10026,2915,119,386Jan 31, 2022, 11:26 AM
Peyer JamesDirectorJan 25, 2022 Buy$4.8620,10097,6865,083,386Jan 27, 2022, 10:31 AM
Peyer JamesDirectorJan 26, 2022 Buy$4.6229,900138,1385,113,286Jan 27, 2022, 10:31 AM
Cambrian BioPharma Inc10% OwnerJan 26, 2022 Buy$4.6229,900138,1385,113,286Jan 27, 2022, 10:26 AM
Cambrian BioPharma Inc10% OwnerJan 25, 2022 Buy$4.8620,10097,6865,083,386Jan 27, 2022, 10:26 AM
Peyer JamesDirectorJan 24, 2022 Buy$4.6922,707106,4965,063,286Jan 25, 2022, 09:14 AM
Peyer JamesDirectorJan 21, 2022 Buy$4.9424,703122,0335,040,579Jan 25, 2022, 09:14 AM
Cambrian BioPharma Inc10% OwnerJan 24, 2022 Buy$4.6922,707106,4965,063,286Jan 25, 2022, 09:12 AM
Cambrian BioPharma Inc10% OwnerJan 21, 2022 Buy$4.9424,703122,0335,040,579Jan 25, 2022, 09:12 AM
Peyer JamesDirectorJan 20, 2022 Buy$5.1720,000103,4005,015,876Jan 21, 2022, 06:20 PM
Peyer JamesDirectorJan 19, 2022 Buy$4.9710,24450,9134,995,876Jan 21, 2022, 06:20 PM
Cambrian BioPharma Inc10% OwnerJan 20, 2022 Buy$5.1720,000103,4005,015,876Jan 21, 2022, 06:16 PM
Cambrian BioPharma Inc10% OwnerJan 19, 2022 Buy$4.9710,24450,9134,995,876Jan 21, 2022, 06:16 PM
Peyer JamesDirectorJan 18, 2022 Buy$5.0810,00050,8004,985,632Jan 20, 2022, 09:07 AM
Cambrian BioPharma Inc10% OwnerJan 18, 2022 Buy$5.0810,00050,8004,985,632Jan 20, 2022, 09:05 AM
Peyer JamesDirectorJan 14, 2022 Buy$4.996,21931,0334,975,632Jan 18, 2022, 10:20 AM
Peyer JamesDirectorJan 13, 2022 Buy$5.1319,953102,3594,969,413Jan 18, 2022, 10:20 AM
Cambrian BioPharma Inc10% OwnerJan 14, 2022 Buy$4.996,21931,0334,975,632Jan 18, 2022, 10:17 AM
Cambrian BioPharma Inc10% OwnerJan 13, 2022 Buy$5.1319,953102,3594,969,413Jan 18, 2022, 10:17 AM
Peyer JamesDirectorJan 12, 2022 Buy$5.229,20248,0344,949,460Jan 13, 2022, 04:14 PM
Peyer JamesDirectorJan 11, 2022 Buy$5.1810,84556,1774,940,258Jan 13, 2022, 04:14 PM
Cambrian BioPharma Inc10% OwnerJan 11, 2022 Buy$5.1810,84556,1774,940,258Jan 13, 2022, 04:13 PM
Cambrian BioPharma Inc10% OwnerJan 12, 2022 Buy$5.229,20248,0344,949,460Jan 13, 2022, 04:13 PM
Peyer JamesDirectorJan 10, 2022 Buy$5.2810,00052,8004,929,413Jan 11, 2022, 03:29 PM
Cambrian BioPharma Inc10% OwnerJan 10, 2022 Buy$5.2810,00052,8004,929,413Jan 11, 2022, 03:22 PM
Peyer JamesDirectorDec 30, 2021 Buy$4.851,1275,4664,919,413Jan 03, 2022, 09:40 AM
Cambrian BioPharma Inc10% OwnerDec 30, 2021 Buy$4.851,1275,4664,919,413Jan 03, 2022, 09:38 AM
Peyer JamesDirectorDec 29, 2021 Buy$4.9869,000343,6204,918,286Dec 30, 2021, 12:25 PM
Cambrian BioPharma Inc10% OwnerDec 29, 2021 Buy$4.9869,000343,6204,918,286Dec 30, 2021, 12:24 PM
Peyer JamesDirectorDec 28, 2021 Buy$5.2811,28859,6014,849,286Dec 29, 2021, 12:04 PM
Cambrian BioPharma Inc10% OwnerDec 28, 2021 Buy$5.2811,28859,6014,849,286Dec 29, 2021, 11:37 AM
Peyer JamesDirectorDec 27, 2021 Buy$5.303,71219,6744,837,998Dec 27, 2021, 06:08 PM
Cambrian BioPharma Inc10% OwnerDec 27, 2021 Buy$5.303,71219,6744,837,998Dec 27, 2021, 06:04 PM
Peyer JamesDirectorDec 23, 2021 Buy$5.2711,00057,9704,834,286Dec 23, 2021, 06:55 PM
Cambrian BioPharma Inc10% OwnerDec 23, 2021 Buy$5.2711,00057,9704,834,286Dec 23, 2021, 06:53 PM
Peyer JamesDirectorDec 17, 2021 Buy$5.291176194,823,286Dec 21, 2021, 03:54 PM
Cambrian BioPharma Inc10% OwnerDec 17, 2021 Buy$5.291176194,823,286Dec 21, 2021, 03:48 PM
Cambrian BioPharma Inc10% OwnerDec 16, 2021 Buy$5.2510,92557,3564,823,169Dec 20, 2021, 05:23 PM
Peyer JamesDirectorDec 16, 2021 Buy$5.2510,92557,3564,823,169Dec 20, 2021, 05:18 PM
RICKS THOMAS GDirectorDec 09, 2021 Buy$6.6220,000132,400321,769Dec 13, 2021, 04:15 PM
RICKS THOMAS GDirectorDec 10, 2021 Buy$5.8620,000117,200341,769Dec 13, 2021, 04:15 PM
Pierce Robert HamiltonChief Scientific OfficerAug 11, 2021 Sale$7.3416,030117,7180Aug 12, 2021, 05:07 PM
Pierce Robert HamiltonChief Scientific OfficerAug 10, 2021 Sale$7.1366,350473,00316,030Aug 10, 2021, 05:40 PM
Pierce Robert HamiltonChief Scientific OfficerAug 09, 2021 Sale$7.066,98249,29582,380Aug 10, 2021, 05:40 PM
Pierce Robert HamiltonChief Scientific OfficerAug 06, 2021 Sale$7.116,46045,94889,362Aug 10, 2021, 05:40 PM
Peyer JamesDirectorMay 05, 2021 Buy$12.003504,2004,812,244May 06, 2021, 04:34 PM
Cambrian BioPharma Inc10% OwnerApr 20, 2021 Buy$12.773854,9164,811,894Apr 21, 2021, 03:52 PM
Peyer JamesDirectorApr 19, 2021 Buy$13.381,96526,2924,811,509Apr 20, 2021, 03:37 PM
Cambrian BioPharma Inc10% OwnerApr 19, 2021 Buy$13.381,96526,2924,811,509Apr 20, 2021, 03:31 PM
Cambrian BioPharma Inc10% OwnerApr 13, 2021 Buy$14.002,00028,0004,809,544Apr 14, 2021, 05:00 PM
Peyer JamesDirectorApr 13, 2021 Buy$14.002,00028,0004,809,544Apr 14, 2021, 04:41 PM
Peyer JamesDirectorApr 07, 2021 Buy$14.002,00028,0004,807,544Apr 08, 2021, 06:13 PM
Cambrian BioPharma Inc10% OwnerApr 01, 2021 Buy$14.001,00014,0004,805,544Apr 02, 2021, 02:58 PM
Peyer JamesDirectorApr 01, 2021 Buy$14.001,00014,0004,805,544Apr 02, 2021, 02:56 PM
Cambrian BioPharma Inc10% OwnerMar 30, 2021 Buy$12.002,00024,0004,804,544Mar 31, 2021, 03:43 PM
Peyer JamesDirectorMar 30, 2021 Buy$12.002,00024,0004,804,544Mar 31, 2021, 03:41 PM
Peyer JamesDirectorMar 24, 2021 Buy$14.123,75052,9504,802,544Mar 25, 2021, 12:40 PM
Cambrian BioPharma Inc10% OwnerMar 24, 2021 Buy$14.123,75052,9504,802,544Mar 25, 2021, 12:37 PM
Peyer JamesDirectorMar 23, 2021 Buy$14.3410,000143,4004,798,794Mar 24, 2021, 04:21 PM
Cambrian BioPharma Inc10% OwnerMar 23, 2021 Buy$14.3410,000143,4004,798,794Mar 24, 2021, 04:19 PM
Cambrian BioPharma Inc10% OwnerMar 22, 2021 Buy$15.022,18332,7894,788,794Mar 23, 2021, 12:34 PM
Peyer JamesDirectorMar 22, 2021 Buy$15.022,18332,7894,788,794Mar 23, 2021, 12:32 PM
Cambrian BioPharma Inc10% OwnerMar 18, 2021 Buy$15.2581712,4594,786,611Mar 19, 2021, 03:51 PM
Peyer JamesDirectorMar 18, 2021 Buy$15.2581712,4594,786,611Mar 19, 2021, 03:44 PM
Peyer JamesDirectorMar 08, 2021 Buy$15.251,00015,2494,785,794Mar 10, 2021, 05:37 PM
Cambrian BioPharma Inc10% OwnerMar 08, 2021 Buy$15.251,00015,2494,785,794Mar 10, 2021, 05:35 PM
Cambrian BioPharma Inc10% OwnerMar 05, 2021 Buy$13.758,000110,0004,784,794Mar 08, 2021, 04:55 PM
Peyer JamesDirectorMar 05, 2021 Buy$13.758,000110,0004,784,794Mar 08, 2021, 04:48 PM
Cambrian BioPharma Inc10% OwnerMar 04, 2021 Buy$14.132,00028,2504,776,794Mar 05, 2021, 01:57 PM
Cambrian BioPharma Inc10% OwnerMar 03, 2021 Buy$15.853,00047,5504,774,794Mar 05, 2021, 01:57 PM
Peyer JamesDirectorMar 04, 2021 Buy$14.132,00028,2504,776,794Mar 05, 2021, 01:55 PM
Peyer JamesDirectorMar 03, 2021 Buy$15.853,00047,5504,774,794Mar 05, 2021, 01:55 PM
Peyer JamesDirectorMar 02, 2021 Buy$16.253,00048,7504,771,794Mar 03, 2021, 05:22 PM
Cambrian BioPharma Inc10% OwnerMar 02, 2021 Buy$16.253,00048,7504,771,794Mar 03, 2021, 12:00 AM
Peyer JamesDirectorFeb 26, 2021 Buy$16.255,00081,2504,768,794Mar 02, 2021, 04:15 PM
Cambrian BioPharma Inc10% OwnerFeb 26, 2021 Buy$16.255,00081,2504,768,794Mar 02, 2021, 04:15 PM
Peyer JamesDirectorFeb 24, 2021 Buy$16.9119,000321,3824,751,794Feb 26, 2021, 04:05 PM
Peyer JamesDirectorFeb 25, 2021 Buy$15.7912,000189,4804,763,794Feb 26, 2021, 04:05 PM
Cambrian BioPharma Inc10% OwnerFeb 25, 2021 Buy$15.7912,000189,4804,763,794Feb 26, 2021, 04:05 PM
Cambrian BioPharma Inc10% OwnerFeb 24, 2021 Buy$16.9119,000321,3824,751,794Feb 26, 2021, 04:05 PM
Peyer JamesDirectorFeb 23, 2021 Buy$17.7920,300361,0704,732,794Feb 25, 2021, 05:55 PM
Cambrian BioPharma Inc10% OwnerFeb 23, 2021 Buy$17.7920,300361,0704,732,794Feb 25, 2021, 05:55 PM
Cambrian BioPharma Inc10% OwnerFeb 22, 2021 Buy$18.889,802185,0624,712,494Feb 24, 2021, 08:32 PM
Peyer JamesDirectorFeb 22, 2021 Buy$18.889,802185,0624,712,494Feb 24, 2021, 08:27 PM
Peyer JamesDirectorFeb 19, 2021 Buy$19.7711,786233,0094,702,692Feb 23, 2021, 04:15 PM
Cambrian BioPharma Inc10% OwnerFeb 19, 2021 Buy$19.7711,786233,0094,702,692Feb 23, 2021, 04:15 PM
Peyer JamesDirectorFeb 18, 2021 Buy$19.7575314,8724,690,906Feb 19, 2021, 04:15 PM
Cambrian BioPharma Inc10% OwnerFeb 18, 2021 Buy$19.7575314,8724,690,906Feb 19, 2021, 04:15 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Peyer JamesDirector03/02/20223,850
Cambrian BioPharma Inc10% Owner03/02/20223,850
Peyer JamesDirector03/23/2021136,230
Peyer JamesDirector02/18/202114,852
Cambrian BioPharma Inc10% Owner03/23/2021136,230
Cambrian BioPharma Inc10% Owner02/18/202114,852
Cambrian BioPharma Inc10% Owner03/02/20223,850
Peyer JamesDirector03/02/20223,850
Peyer JamesDirector03/01/20228,849
Peyer JamesDirector02/28/2022151
Cambrian BioPharma Inc10% Owner02/28/2022151
Cambrian BioPharma Inc10% Owner03/01/20228,849
Peyer JamesDirector02/25/20229,125
Cambrian BioPharma Inc10% Owner02/25/20229,125
Cambrian BioPharma Inc10% Owner02/24/202254,450
Cambrian BioPharma Inc10% Owner02/23/20229,500
Peyer JamesDirector02/24/202254,450
Peyer JamesDirector02/23/20229,500
Peyer JamesDirector02/18/202259,550
Peyer JamesDirector02/17/202220,637
Cambrian BioPharma Inc10% Owner02/18/202259,550
Cambrian BioPharma Inc10% Owner02/17/202220,637
Cambrian BioPharma Inc10% Owner02/16/202210,842
Cambrian BioPharma Inc10% Owner02/14/202241,800
Peyer JamesDirector02/16/202210,842
Peyer JamesDirector02/14/202241,800
Peyer JamesDirector02/10/202222,900
Peyer JamesDirector02/11/202255,000
Cambrian BioPharma Inc10% Owner02/11/202255,000
Cambrian BioPharma Inc10% Owner02/10/202222,900
Cambrian BioPharma Inc10% Owner02/08/202243,300
Cambrian BioPharma Inc10% Owner02/04/202211,125
Cambrian BioPharma Inc10% Owner02/03/202281,375
Peyer JamesDirector02/03/202281,375
Peyer JamesDirector02/08/202243,300
Peyer JamesDirector02/04/202211,125
Cambrian BioPharma Inc10% Owner01/28/202237,558
Cambrian BioPharma Inc10% Owner01/27/202226,291
Peyer JamesDirector01/28/202237,558
Peyer JamesDirector01/27/202226,291
Peyer JamesDirector01/25/202297,686
Peyer JamesDirector01/26/2022138,138
Cambrian BioPharma Inc10% Owner01/26/2022138,138
Cambrian BioPharma Inc10% Owner01/25/202297,686
Peyer JamesDirector01/24/2022106,496
Peyer JamesDirector01/21/2022122,033
Cambrian BioPharma Inc10% Owner01/24/2022106,496
Cambrian BioPharma Inc10% Owner01/21/2022122,033
Peyer JamesDirector01/20/2022103,400
Peyer JamesDirector01/19/202250,913
Cambrian BioPharma Inc10% Owner01/20/2022103,400
Cambrian BioPharma Inc10% Owner01/19/202250,913
Peyer JamesDirector01/18/202250,800
Cambrian BioPharma Inc10% Owner01/18/202250,800
Peyer JamesDirector01/14/202231,033
Peyer JamesDirector01/13/2022102,359
Cambrian BioPharma Inc10% Owner01/14/202231,033
Cambrian BioPharma Inc10% Owner01/13/2022102,359
Peyer JamesDirector01/12/202248,034
Peyer JamesDirector01/11/202256,177
Cambrian BioPharma Inc10% Owner01/11/202256,177
Cambrian BioPharma Inc10% Owner01/12/202248,034
Peyer JamesDirector01/10/202252,800
Cambrian BioPharma Inc10% Owner01/10/202252,800
Peyer JamesDirector12/30/20215,466
Cambrian BioPharma Inc10% Owner12/30/20215,466
Peyer JamesDirector12/29/2021343,620
Cambrian BioPharma Inc10% Owner12/29/2021343,620
Peyer JamesDirector12/28/202159,601
Cambrian BioPharma Inc10% Owner12/28/202159,601
Peyer JamesDirector12/27/202119,674
Cambrian BioPharma Inc10% Owner12/27/202119,674
Peyer JamesDirector12/23/202157,970
Cambrian BioPharma Inc10% Owner12/23/202157,970
Peyer JamesDirector12/17/2021619
Cambrian BioPharma Inc10% Owner12/17/2021619
Cambrian BioPharma Inc10% Owner12/16/202157,356
Peyer JamesDirector12/16/202157,356
RICKS THOMAS GDirector12/09/2021132,400
RICKS THOMAS GDirector12/10/2021117,200
Pierce Robert HamiltonChief Scientific Officer08/11/2021117,718
Pierce Robert HamiltonChief Scientific Officer08/10/2021473,003
Pierce Robert HamiltonChief Scientific Officer08/09/202149,295
Pierce Robert HamiltonChief Scientific Officer08/06/202145,948
Peyer JamesDirector05/05/20214,200
Cambrian BioPharma Inc10% Owner04/20/20214,916
Peyer JamesDirector04/19/202126,292
Cambrian BioPharma Inc10% Owner04/19/202126,292
Cambrian BioPharma Inc10% Owner04/13/202128,000
Peyer JamesDirector04/13/202128,000
Peyer JamesDirector04/07/202128,000
Cambrian BioPharma Inc10% Owner04/01/202114,000
Peyer JamesDirector04/01/202114,000
Cambrian BioPharma Inc10% Owner03/30/202124,000
Peyer JamesDirector03/30/202124,000
Peyer JamesDirector03/24/202152,950
Cambrian BioPharma Inc10% Owner03/24/202152,950
Peyer JamesDirector03/23/2021143,400
Cambrian BioPharma Inc10% Owner03/23/2021143,400
Cambrian BioPharma Inc10% Owner03/22/202132,789
Peyer JamesDirector03/22/202132,789
Cambrian BioPharma Inc10% Owner03/18/202112,459
Peyer JamesDirector03/18/202112,459
Peyer JamesDirector03/08/202115,249
Cambrian BioPharma Inc10% Owner03/08/202115,249
Cambrian BioPharma Inc10% Owner03/05/2021110,000
Peyer JamesDirector03/05/2021110,000
Cambrian BioPharma Inc10% Owner03/04/202128,250
Cambrian BioPharma Inc10% Owner03/03/202147,550
Peyer JamesDirector03/04/202128,250
Peyer JamesDirector03/03/202147,550
Peyer JamesDirector03/02/202148,750
Cambrian BioPharma Inc10% Owner03/02/202148,750
Peyer JamesDirector02/26/202181,250
Cambrian BioPharma Inc10% Owner02/26/202181,250
Peyer JamesDirector02/24/2021321,382
Peyer JamesDirector02/25/2021189,480
Cambrian BioPharma Inc10% Owner02/25/2021189,480
Cambrian BioPharma Inc10% Owner02/24/2021321,382
Peyer JamesDirector02/23/2021361,070
Cambrian BioPharma Inc10% Owner02/23/2021361,070
Cambrian BioPharma Inc10% Owner02/22/2021185,062
Peyer JamesDirector02/22/2021185,062
Peyer JamesDirector02/19/2021233,009
Cambrian BioPharma Inc10% Owner02/19/2021233,009
Peyer JamesDirector02/18/202114,872
Cambrian BioPharma Inc10% Owner02/18/202114,872
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2022
06/30/2022
0.05%
1Q
09/30/2022
12/31/2021
10.75%
3Q
09/30/2022
09/30/2021
14.79%
4Q
09/30/2022
06/30/2021
23.86%
5Q
Load More

Period of Report: 09/30/2022

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2022
0.05%
1Q
12/31/2021
10.75%
3Q
09/30/2021
14.79%
4Q
06/30/2021
23.86%
5Q
Load More